A disease of humans and animals that resembles GLANDERS. It is caused by BURKHOLDERIA PSEUDOMALLEI and may range from a dormant infection to a condition that causes multiple abscesses, pneumonia, and bacteremia.
Excerpt | Reference |
"An instance of melioidosis is described in a five-year-old Papua New Guinean." | ( De Buse, PJ; Henderson, A; White, M, 1975) |
"Melioidosis is an infectious disease caused by Pseudomonas pseudomallei." | ( Pui, MH; Tan, AP; Tan, LK, 1995) |
"The pathogenesis of melioidosis is not well understood, and the role of various extracellular enzymes produced by P." | ( Chaowagul, W; Jones, AL; Sexton, MM; Woods, DE, 1994) |
"Melioidosis is an uncommon infection caused by a Gram-negative bacillus, Pseudomonas pseudomallei." | ( Prichasuk, S; Sathapatayavongs, B; Subhadrabandhu, T, 1995) |
"We surmise that melioidosis is underdiagnosed and underreported in India and we alert clinicians, microbiologists and public health professionals to the possibility of melioidosis being far more common than previously recognised." | ( Chandy, MJ; Cherian, T; Ganesh, A; Jesudason, MV; John, TJ; Lalitha, MK; Mathai, D; Mohandas, V, 1996) |
"Melioidosis is known to present with many diverse manifestations but orbital cellulitis from melioidosis has never been described." | ( Ng, PH; Wong, PK, 1996) |
"pseudomallei." | ( Dance, DA; Pitt, TL; Smith, MD; Walsh, AL; White, NJ; Wuthiekanun, V, 1996) |
"Melioidosis is most frequently encountered in pulmonary localization." | ( Perret, JL; Thibault, F; Vidal, D, 1998) |
"Melioidosis is a protean disease caused by Burkholderia pseudomallei." | ( Gage, A; Minassian, MA; Price, E; Sefton, AM, 1999) |
"Melioidosis is the term given to any infection caused by Burkholderia pseudomallei." | ( Ahmed, K; Gori, AH; Martinez, G; Masaki, H; Nagatake, T; Watanabe, K, 1999) |
"Melioidosis is a tropical disease caused by Burkholderia pseudomallei, which is common in southeast Asia and Australia, but which is rarely diagnosed in Scandinavia." | ( Carlson, P; Seppänen, M, 2000) |
"Severe melioidosis is a life-threatening, systemic bacterial infection caused by Burkholderia pseudomallei." | ( Angus, BJ; Chaowagul, W; Opal, SM; Palardy, JE; Parejo, NA; Prins, JM; Simpson, AJ; White, NJ, 2000) |
"Whereas melioidosis is a significant cause of morbidity in south-east Asia, glanders is extremely rare." | ( Bell, DL; Eley, SM; Ellis, J; Green, M; Kenny, DJ; Russell, P; Titball, RW, 2000) |
"Septicemic melioidosis is often fatal despite treatment with antibiotics such as ceftazidime to which Burkholderia pseudomallei, the causal pathogen, is sensitive in vitro." | ( Clair, A; Golledge, CL; Harvey, J; Inglis, TJ, 2001) |
"Melioidosis is an important public health problem in some regions, and a potential bioweapon." | ( Dance, DA, 2002) |
"Melioidosis is endemic in Southeast Asia and Northern Australia." | ( Driessen, JT; Leeuwenburgh, I; Stijnen, PJ; van Keulen, PH; Verburg, GP, 2002) |
"Melioidosis is caused by the Gram-negative bacillus Burkholderia pseudomallei." | ( Bowden, B; Hirst, R; Norton, R; Powell, K; Ulett, GC, 2003) |
"Melioidosis is an infectious disease that occurs in tropical regions, particularly in Thailand." | ( Samuel, M; Ti, TY, 2002) |
"Melioidosis is an acute infectious disease caused by a safety-pin-shaped gram-negative bacteria called Burkholderia pseudomallei." | ( Bhattacharya, S; Jayanthi, S; Kanungo, R; Padhan, P; Srimannarayana, J; Swaminathan, RP, 2002) |
"Melioidosis is an emerging infection in India." | ( Anbarasu, A; Jesudason, MV; John, TJ, 2003) |
"Melioidosis is a life-threatening disease caused by Burkholderia pseudomallei." | ( Anuntagool, N; Arjcharoen, S; Chaisuriya, P; Lengwehasatit, I; Limposuwan, K; Sirisinha, S; Utaisincharoen, P, 2004) |
"Melioidosis is an important public health problem in some regions of the world." | ( Chaudhry, R; Dhawan, B, 2004) |
"Melioidosis is much less common in children than in adults." | ( How, HS; Ng, KH; Shah, A; Tee, HP; Yeo, HB, 2005) |
"Acute septicemic melioidosis is associated with systemic release of endotoxin and the proinflammatory cytokines tumor necrosis factor (TNF)-alpha, interleukin-1, and interleukin-6." | ( Chaowagul, W; Fisher, CJ; Helterbrand, J; LaRosa, SP; Opal, SM; Simpson, AJ; Utterback, B; White, NJ; Yan, SC, 2006) |
"Melioidosis is a severe, chronic infection which is endemic in Thailand and is caused by Burkholderia pseudomallei." | ( Claesson, BA; Studahl, M; Svensson, E; Welinder-Olsson, C, 2006) |
"Melioidosis is caused by an infection by Burkholderia pseudomallei." | ( Kwan, MK; Merican, AM; Ng, WM, 2006) |
"Neurological melioidosis is unusual but meningoencephalitis, encephalomyelitis and brain microabscess can occur Dural sinus thrombosis is not an uncommon cerebrovascular disorder with various etiologies." | ( Niyasom, S; Sithinamsuwan, P; Suwantamee, J; Udommongkol, C, 2006) |
"Melioidosis is an endemic disease in southeast Asia and northern Australia, caused by Burkholderia pseudomallei." | ( Chan, KS; Chen, CM; Cheng, KC; Tan, CK; Yu, WL, 2007) |
"Melioidosis is a tropical disease caused by infection with the bacterium Burkholderia pseudomallei." | ( De Dobbeeler, G; Ezzedine, K; Heenen, M; Jacobs, F; Malvy, D; Steels, E; Struelens, M, 2007) |
"Melioidosis is a bacterial infection caused by the Gram-negative bacillus Burkholderia pseudomallei." | ( Lim, KB; Oh, HM, 2007) |
"Melioidosis is an emerging disease of humans in Southeast Asia and tropical Australia." | ( Atkins, HS; Atkins, TP; Bancroft, G; Brown, KA; Chu, K; Haque, A; Harland, DN; Moore, B; Nelson, M; Sarkar-Tyson, M; Titball, RW; Walker, NJ, 2007) |
"Melioidosis is a suppurative chronic infection caused by a gramnegative bacterium, Burkholderia pseudomallei." | ( Amte, A; Balaji, V; Jesudason, MV; Jeyamani, R; Kurian, G; Mukhopadhya, A, 2007) |
"It is probable that melioidosis is highly prevalent in western coastal India and yet, greatly underestimated." | ( Bharathi, B; Shrikala, B; Suchitra, U; Vidyalakshmi, K, 2007) |
"Melioidosis is an infectious disease endemic to northern Australia and Southeast Asia." | ( Chaowagul, W; Cheng, AC; Chetchotisakd, P; Chierakul, W; Currie, BJ; Dance, DA; Limmathurotsakul, D; Peacock, SJ, 2008) |
"Melioidosis is an infectious disease caused by Burkholderia pseudomallei that is endemic in Southeast Asia and northern Australia and has also been reported from non-endemic areas of the world." | ( Raja, NS, 2008) |
"Melioidosis is expanding in endemicity around the world." | ( Raja, NS, 2008) |
"Melioidosis is an emerging infectious disease in India acquired through percutaneous inoculation or contaminated water." | ( Choudhary, R; Fernandes, S; Krishnan, P; Pais, P; Pradeep, R; Ross, CR; Savio, J; Shet, AS, 2008) |
"Melioidosis is endemic in Malaysia." | ( Ariza, A, 2008) |
"Melioidosis is sporadically reported from various parts of India." | ( Bairy, I; Barkur, AS; Kumar, RS; Mukhyopadhyay, C; Saravu, K; Varghese, GK; Vishwanath, S, 2008) |
"Melioidosis is caused by Burkholderia pseudomallei, a Gram-negative bacillus." | ( Amran, AR; How, SH; Kuan, YC; Ng, TH; Razali, MR, 2009) |
"Melioidosis is an infectious disease with a propensity for relapse, despite prolonged antibiotic eradication therapy for 12 to 20 weeks." | ( Amornchai, P; Cheng, AC; Chierakul, W; Day, NP; McBryde, ES; Peacock, SJ; White, NJ; Wuthiekanun, V, 2009) |
"Melioidosis is an underdiagnosed and underreported disease in India with protean clinical manifestations." | ( Chrispal, A; Rajan, SJ; Sathyendra, S, 2010) |
"On the other hand, melioidosis is a newly emerging disease from this region, which is most often misdiagnosed or underdiagnosed by clinicians." | ( Gonsalves, H; Maneesh, M; Mukhopadhyay, C; Pandit, VR; Rau, NR; Saravu, K; Shastry, BA; Shubha, S; Valsalan, R, 2009) |
"Melioidosis is rare in the UK and western world; however, exposure can occur during travel to endemic areas." | ( Garas, G; Ifeacho, S; Millard, R; Tolley, N, 2010) |
"Melioidosis is an emerging infection in India." | ( Antony, B; Boloor, R; Dias, M; Kuruvilla, T; Pinto, H; Scaria, B; Shetty, AK, 2010) |
"Melioidosis is an important public health problem causing community acquired sepsis in the northeastern part of Malaysia." | ( Deris, ZZ; Hasan, H; Siti Suraiya, MN, 2010) |
"Melioidosis is an infectious disease caused by the soil-associated Gram-negative bacterium Burkholderia pseudomallei." | ( Cheng, AC, 2010) |
"Melioidosis is an important cause of sepsis in the tropics, is caused by an environmental saprophyte--B." | ( Puthucheary, SD, 2009) |
"Melioidosis is an important disease in Asia and Australia." | ( Caldera, J; Calvo, A; Figuera, M; Gómez, M; Guevara, RN; Khalil, R; Landaeta, ME; Morón, M; Nuñez, MJ; Palavecino, S; Redondo, MC; Ríos, H; Rivera, R; Vitelli, J, 2011) |
"Melioidosis is an infectious disease caused by Burkholderia pseudomallei and endemic in Southeast Asia." | ( Chua, KH; Puthucheary, SD; See, KH; Thong, KL, 2010) |
"Melioidosis is potentially preventable, but there is a striking lack of evidence on which to base an effective prevention programme." | ( Limmathurotsakul, D; Peacock, SJ, 2011) |
"Melioidosis is quite prevalent in the western coastal region of India, and is strongly associated with rainfall, age, and diabetes mellitus." | ( Chakrapani, M; Damodar, S; Lipika, S; Vidyalakshmi, K; Vishal, S, 2012) |
"Burkholderia pseudomallei infections are fastidious to treat with conventional antibiotic therapy, often involving a combination of drugs and long-term regimes." | ( Jones-Carson, J; Laughlin, JR; Stewart, AL; Vázquez-Torres, A; Voskuil, MI, 2012) |
"Melioidosis is an infection caused by Burkholderia pseudomallei." | ( Jankar, R; Kalal, C; Khare, S; Rajadhyaksha, A; Sonawale, A, 2012) |
"Melioidosis is a disease in tropical and subtropical regions of the world that is caused by Burkholderia pseudomallei." | ( Bowen, RA; Dascher, K; Eckstein, TM; Gonzalez-Juarrero, M; Mima, N; Mwangi, W; Schweizer, HP; Trunck, LA, 2013) |
"Melioidosis is caused by the soil-borne pathogen Burkholderia pseudomallei." | ( Chan, H; Chang, HH; Chen, YL; Chen, YS; Goldsmith, CS; Greer, PW; Metcalfe, MG; Shieh, WJ; Zaki, SR, 2014) |
"Treatment for melioidosis is unaffordable for many in endemic areas of the developing world, but the relative costs have reduced over the past decade." | ( Dance, D, 2014) |
"Melioidosis is an emerging infection in India especially in males from rural areas, with diabetes and alcoholism being the commonest risk factors." | ( Gopalakrishnan, R; Ramasubramanian, V; Sureshkumar, D; Thirunarayan, MA, 2013) |
"Melioidosis is endemic to northern Australia and Southeast Asia." | ( Baird, RW; Crowe, A; Currie, BJ; McMahon, N, 2014) |
"Melioidosis is an often fatal infectious disease affecting humans and animals in the tropics." | ( Andriamalala, NC; Currie, BJ; Djaomazala, I; Dubois-Cauwelaert, N; Garin, B; Herindrainy, P; Kaestli, M; Mayo, M; Raharimanga, V; Ralison, F; Sarovich, DS, 2014) |
"Melioidosis is caused by the environmental bacterium Burkholderia pseudomallei and can present with severe sepsis." | ( Commons, RJ; Currie, BJ; Grivas, R, 2014) |
"Melioidosis is a tropical bacterial infection caused by Burkholderia pseudomallei (B." | ( Abd Rahman, N; Antony, T; Joseph, S; Lakshminarasimhan, A; Lau, MS; Lekshmi, SU; Nathan, S; Ramachandra, M; Rao, KN; Sreenivas, K; Subramanya, H; Takhi, M; Yusof, R, 2015) |
"Melioidosis is an important cause of community-acquired infection in Southeast Asia and northern Australia." | ( Fong, SM; Fukushima, M; Wong, KJ; Yeo, TW, 2015) |
"Melioidosis is an often fatal infectious disease affecting humans and animals in tropical regions and is caused by the saprophytic environmental bacterium Burkholderia pseudomallei." | ( Chatfield, MD; Currie, BJ; Gibb, K; Harrington, G; Harrington, I; Hill, A; Kaestli, M; Mayo, M; Munksgaard, N, 2015) |
"Epidemiology of melioidosis is poorly understood because its occurrence is influenced by complex interaction of environmental, climatic, physicochemical and host factors." | ( Abdul Aziz, S; Hassan, L; Musa, HI; Panchadcharam, C; Rachmat, RF; Shamsuddin, ZH; Zakaria, Z, 2015) |
"Melioidosis is a common community-acquired infectious disease in northeast Thailand associated with overall mortality of approximately 40% in hospitalized patients, and over 70% in severe cases." | ( Anunnatsiri, S; Cheah, P; Cheah, PY; Chetchotisakd, P; Chierakul, W; Currie, BJ; Day, NP; Hantrakun, V; Limmathurotsakul, D; Lubell, Y; Peacock, SJ, 2015) |
"Melioidosis is a severe disease caused by the Gram-negative bacterium Burkholderia pseudomallei." | ( Brett, PJ; Burtnick, MN; Chantratita, N; Day, NPJ; Douglas, Z; Limmathurotsakul, D; Suttisunhakul, V; Wikraiphat, C; Wuthiekanun, V, 2015) |
"Melioidosis is an infection caused by Gram-negative bacterium, Burkholderia pseudomallei." | ( Chawla, K; Chawla, N; Garg, G; Jain, S; Khosla, P, 2015) |
"Melioidosis is increasing in incidence with newly recognized foci of melioidosis in the Americas, Africa, and elsewhere." | ( Currie, BJ; Stephens, DP; Thomas, JH; Ward, LM, 2016) |
"Although melioidosis, is an important disease in many Southeast Asian countries and Australia, there is limited data on its prevalence and disease burden in India." | ( Bhat, V; Kamath, A; Mukhopadhyay, C; Sathiakumar, N; Tellapragada, C; Tipre, M; Vandana, KE, 2016) |
"Melioidosis is an emerging infectious disease caused by Burkholderia pseudomallei and is associated with high morbidity and mortality rates in endemic areas." | ( Atkins, TP; Campbell, AS; Christ, WJ; George, AJ; Guo, Y; Jones, M; Lohman, GJ; Prior, JL; Scott, AE; Stokes, MG; Titball, RW, 2016) |
"Melioidosis is a potential problem among Chinese imigrant workers with strains new to China being identified." | ( Deng, Y; Wang, X; Zong, Z, 2016) |
"Melioidosis is an uncommon tropical infectious disease caused by Burkholderia pseudomallei." | ( Krishnamurthy, S; Lalitha, M; Mahadevan, S; Nagarajan, K; Prasanna Kumar, M; Sistla, S; Venkateswaran, VS, 2017) |
"Melioidosis is an emerging infectious disease in Sri Lanka." | ( Dasanayake, D; Fonseka, CL; Galappaththi, SR; Illagatilaka, A; Tissera, N, 2016) |
"Melioidosis is a major public health concern in endemic regions including Southeast Asia and northern Australia." | ( Batra, HV; Gogoi, M; Nagaraj, S; Paul, S; Peddayelachagiri, BV; Sripathy, MH, 2016) |
"Melioidosis is caused by the facultative intracellular bacterium Burkholderia pseudomallei and is potentially fatal." | ( Afzali, MF; Allen, CP; Cummings, JE; Hanneman, WH; Legare, ME; Slayden, RA; Tjalkens, RB; Wilson, WJ, 2016) |
"Melioidosis is a tropical infectious disease associated with significant mortality due to early onset of sepsis." | ( Kingsley, PV; Leader, M; Nagodawithana, NS; Sathiakumar, N; Tipre, M, 2016) |
"Melioidosis is an endemic disease in Southeast Asia and North Australia which in some cases can run a severe course and can have a high fatality rate." | ( Fleck, R; Ignatius, R; Oehme, R; Rueda Guzmán, A; Schäfer, J; Slesak, G, 2017) |
"Melioidosis is a serious, and potentially fatal community-acquired infection endemic to northern Australia and Southeast Asia, including Sarawak, Malaysia." | ( Bantin, R; Chien, SL; Chieng, CH; Chua, WY; Currie, BJ; Goh, C; Hashim, J; Hii, KC; Machunter, B; Mayo, M; Mijen, A; Mohan, A; Ngian, HU; Ooi, MH; Podin, Y; Rigas, V; Tai, N; Tan, LS; Wong, D; Wong, JS; Wong, SC, 2017) |
"Melioidosis is caused by the bacterium Burkholderia pseudomallei." | ( Engler, C; Maloney, S; Norton, R, 2017) |
"Leishmaniasis and melioidosis are frequently reported from the North Central Province of Sri Lanka." | ( Corea, E; Dassanayake, M; Kahandawaarachchi, ICI; Premawansa, GS; Warnasuriya, W, 2017) |
"Melioidosis is an endemic infectious disease in Southeast Asia and northern Australia, caused by Burkholderia pseudomallei." | ( Ahmad, N; Ali, NA; Amran, F; Hii, SYF, 2017) |
"Melioidosis is endemic in Southeast Asia and tropical Australia with varying clinical features from benign skin lesions to fatal septicaemia." | ( Abdul Halim, NA; Alemam, MMM; Ong, SCL; Zakaria, NA, 2017) |
"Melioidosis is a disease caused by bacteria called B." | ( Allou, N; Allyn, J; Belmonte, O; Bouchet, B; Galas, T; Jaffar-Bandjee, MC; Martinet, O; Traversier, N, 2017) |
"Melioidosis is endemic across tropical areas, especially in southeast Asia and northern Australia." | ( Currie, BJ; Dance, DAB; Limmathurotsakul, D; Peacock, SJ; Torres, AG; Virk, HS; Wiersinga, WJ, 2018) |
"Melioidosis is an emerging infection in the tropics caused by the bacterium Burkholderia pseudomallei." | ( Dalugama, C; Gawarammana, IB; Tennegedara, A, 2018) |
"Because melioidosis is endemic in Southern Taiwan and the use of antipsychotics might mask the symptoms, physicians dealing with patients from endemic areas with a medical history of antipsychotics should always consider the possibility of neurological melioidosis and provide prompt empirical management to suspicious cases." | ( Chen, GB; Chen, LH; Lin, WS; Tuan, SH, 2018) |
"Melioidosis is mainly observed in South-East Asia, where Burkholderia pseudomallei is endemic." | ( Caumes, E; Fertitta, L; Monsel, G; Torresi, J, 2019) |
"Melioidosis is the disease caused by the soil and water bacterium, Burkholderia pseudomallei." | ( Koshy, M; Sadanshiv, P; Sathyendra, S, 2019) |
"Melioidosis is an infection caused by Burkholderia pseudomallei, which is more prevalent in the tropics and leads to significant morbidity and mortality." | ( Amarasena, HLP; Jayamanne, SF; Ranawaka, UK; Silva, FHDS; Tilakaratna, PMYI, 2019) |
"Cerebral melioidosis is an unusual presentation of melioidosis where the diagnosis can be easily missed." | ( Amarasena, HLP; Jayamanne, SF; Ranawaka, UK; Silva, FHDS; Tilakaratna, PMYI, 2019) |
"Melioidosis is a life-threatening infectious disease that is caused by gram negative bacteria Burkholderia pseudomallei." | ( Adhikari, M; Baral, S; Basnyat, B; Pant, V; Sharma, S; Sherchand, JB; Shrestha, A; Shrestha, N, 2019) |
"Melioidosis is a tropical infection, first described in Myanmar but now rarely diagnosed there, which is widespread in Southeast Asia." | ( Aung, WW; Aye, KM; Aye, SN; Dance, DAB; Hla, T; Htay, MT; Htwe, TT; Nyein Win, KK; Phyu, KP; San, KK; Wah, TT; Win, MM, 2019) |
"Melioidosis is gaining recognition as an emerging infectious disease with diverse clinical manifestations and high-case fatality rates worldwide." | ( Kalwaje Eshwara, V; Kamath, A; Mukhopadhyay, C; Shaw, T; Tellapragada, C, 2019) |
"Melioidosis is a protean disease which is endemic to Southeast Asia and northern Australia." | ( Auvens, C; Blot, M; Neuwirth, C; Piroth, L, 2019) |
"Melioidosis is an infectious disease caused by gram negative bacterium Burkholderia pseudomallei." | ( George, E; Rajalakshmi, A, 2019) |
"Melioidosis is considered endemic in certain areas of the world." | ( Abeygunawardana, SP; Dalugama, C; Dissanayake, N; Dissanayake, P; Jayalath, T; Jayawardena, N; Kumarihamy, P; Ralapanawa, U; Ratnatunga, N; Udupihille, J, 2019) |
"Melioidosis is commonly an undiagnosed disease that has a wide variety of clinical presentations." | ( Abeygunawardana, SP; Dalugama, C; Dissanayake, N; Dissanayake, P; Jayalath, T; Jayawardena, N; Kumarihamy, P; Ralapanawa, U; Ratnatunga, N; Udupihille, J, 2019) |
"Melioidosis is caused by Burkholderia pseudomallei, a gram-negative aerobic bacillus, found in the soil and surface water." | ( Chan, YW; Eileen, T; Lam, JE; Lim, SH; Nurasykin, S; Tang, RY, 2019) |
"Melioidosis is characterised by high mortality and morbidity and can involve the central nervous system (CNS)." | ( Batzloff, M; Beacham, IR; Beagley, KW; Chacko, A; Delbaz, A; Ekberg, JAK; Nazareth, L; Shah, M; Shelper, T; St John, JA; Tello Velasquez, J; Walkden, H, 2020) |
"Melioidosis is an infectious disease of tropical climates." | ( Alalwan, B; Aldosary, O; Alharbi, A; Alhatmi, H; Aljohani, S; Almahmoud, S; Alothman, A; Alsaeedi, A; Bosaeed, M, 2020) |
"Melioidosis is associated with extremely high case fatality ratios." | ( Ahmad, R; Chien, SL; Chin, ST; Chuah, TB; Hamli, QI; Lau, PS; Manan, K; Mohan, A; Ooi, MH; Podin, Y; Tan, LS; Tan, YC, 2020) |
"Melioidosis is known as the 'great mimicker' because it presents with a wide range of disease manifestations." | ( Chapartegui-González, I; Khakhum, N; Torres, AG, 2020) |
"Melioidosis is an often-severe tropical infection caused by Burkholderia pseudomallei (Bp) with high associated morbidity and mortality." | ( Chantratita, N; Ducken, D; Hantrakun, V; Limmathurotsakul, D; Lovelace-Macon, L; Tandhavanant, S; Teparrukkul, P; West, TE; Wright, SW, 2020) |
"Melioidosis is a neglected tropical disease with rising global public health and clinical importance." | ( Ahmad, N; Amran, F; Arushothy, R; Nathan, S; Samsuddin, N, 2020) |
"Melioidosis is an endemic disease in southeast Asia and northern Australia caused by the saprophytic bacteria Burkholderia pseudomallei, with a high mortality rate." | ( Biot, F; Boughammoura, A; Degand, N; Favier, AL; Girleanu, M; Gorgé, O; Guillier, S; Koch, L; Neulat-Ripoll, F; Nolent, F; Ramisse, V; Sarilar, V; Schnetterle, M; Tichadou, X; Valade, E; Vigier, C, 2021) |
"Primary prostatic melioidosis is a rare presentation of melioidosis even in melioidosis endemic areas." | ( Ding, CH; Norliyana, N; Nurzam, SCH; Rao, KR; Salbiah, N; Wahab, AA, 2020) |
"Melioidosis is endemic in the State of Sabah, Malaysia." | ( Darwina, A; Lee, HG; Lee, KS; Ooi, SY; Sannasey, S; Soo, KC, 2021) |
"Melioidosis is endemic in India and well described from western and eastern coastal states." | ( Dharsandiya, M; Munim, FC; Patel, A; Patel, K; Savaj, P; Shah, K, 2021) |
"Melioidosis is an infectious disease that is initiated by a bacteria recognized as Burkholderia pseudomallei." | ( Chan, HK; Hassan, MRA; Mardhiah, K; Naing, NN; Wan-Arfah, N, 2021) |
"Melioidosis is a disease of public health importance associated with high case-fatality rates in animals and humans caused by Burkholderia pseudomallei (B." | ( Ahmad, N; Ghazali, S; Hadi, FS; Ramli, SR, 2021) |
"Likewise, melioidosis is one of the major endemic health problems in Malaysia." | ( Azri, M; Ismail, IH, 2022) |
"Melioidosis is an infectious disease caused by Burkholderia pseudomallei." | ( Kamuthachad, L; Kasetthat, T; Matangkasombut, P; Sermswan, RW; Watarai, H; Wongratanacheewin, S, 2022) |
"Human melioidosis is currently under-reported in Southeast Asia and its true prevalence is unknown." | ( Abdullah, NA; Aziah, I; Ganapathy, T; Harun, A; Khalid, MF; Najib, MA; Selvam, K; Wan Mohammad, WMZ, 2022) |
"Human melioidosis is currently under-reported in Southeast Asia and its true prevalence is unknown." | ( Abdullah, NA; Aziah, I; Ganapathy, T; Harun, A; Khalid, MF; Najib, MA; Selvam, K; Wan Mohammad, WMZ, 2022) |
"Melioidosis is an infectious disease caused by the bacterium Burkholderia pseudomallei." | ( Gunathilaka, MGRSS; Jayaweera, JAAS; Keragala, KARK; Senevirathna, RMISK, 2023) |
"Melioidosis is a deadly endemic disease in northern Australia and Southeast Asia, including Sabah, Malaysia, which is caused by the bacterium Burkholderia pseudomallei." | ( Dalusim, F; Hussin, A; Ibrahim, N; Nathan, S; Nor Rahim, MY; Shahidan, MA, 2023) |
"Melioidosis is endemic in Southeast Asia, including Malaysia." | ( Ding, CH; Kori, N; Muttaqillah, NAS; Nordashima, AS; Nurazizah, SMA; Periyasamy, P; Wahab, AA, 2023) |
Excerpt | Reference |
"Fifty-five children with culture-proved melioidosis treated at Srinagarind Hospital from 1979 to 1993 were retrospectively reviewed." | ( Lumbiganon, P; Viengnondha, S, 1995) |
"Efficacious treatment of melioidosis (a glanders-like disease) presupposes diagnosis of the causative microorganism and testing of its antibiotic sensitivity." | ( Koch, FW; Kohl, FV; Küchler, R; Pankow, W; Zöller, M, 1997) |
"Forty of them (48%) had culture-proven melioidosis and were randomly assigned to one of the two treatment groups, each group with 20 patients." | ( Chetchotisakd, P; Thamprajamchit, S; Thinkhamrop, B, 1998) |
"The current treatment choice for severe melioidosis is parenteral ceftazidime followed by oral amoxycillin-clavulanic acid or a combination of co-trimoxazole, doxycycline and chloramphenicol." | ( Gage, A; Minassian, MA; Price, E; Sefton, AM, 1999) |
"Two further treatment trials in acute melioidosis have recently been conducted in Thailand." | ( Chaowagul, W, 2000) |
"Severe melioidosis (Burkholderia pseudomallei infection) carries a mortality over 40% despite treatment with high dose ceftazidime." | ( Angus, BJ; Chaowagul, W; Mattie, H; Smith, MD; Suputtamongkol, Y; Walsh, AL; White, NJ; Wuthiekanun, V, 2000) |
"The recommended treatment for severe melioidosis is ceftazidime or a combination of ceftazidime and trimethoprim-sulfamethoxazole (TMP/SMX)." | ( Lumbiganon, P; Panamonta, O, 2000) |
"Septicemic melioidosis is often fatal despite treatment with antibiotics such as ceftazidime to which Burkholderia pseudomallei, the causal pathogen, is sensitive in vitro." | ( Clair, A; Golledge, CL; Harvey, J; Inglis, TJ, 2001) |
"In the septicaemic form, melioidosis is a serious and life threatening condition which requires early detection and specific treatment to avoid case fatality." | ( Anbarasu, A; Jesudason, MV; John, TJ, 2003) |
"Among patients with melioidosis, there was no difference in death rate between the 2 treatment groups for either all deaths (OR, 0." | ( Anunnatsiri, S; Chaowagul, W; Cheng, AC; Chetchotisakd, P; Chierakul, W; Day, NP; Limmathurotsakul, D; Maharjan, B; Mootsikapun, P; Newton, PN; Peacock, SJ; Short, JM; Simpson, AJ; Stepniewska, K; White, NJ, 2005) |
"Early diagnosis of melioidosis was made by culture and growth of Burkholderia pseudomallei from aspirated pus from the abscesses and the patients were treated with ceftazidime and co-trimoxazole." | ( Amte, A; Balaji, V; Jesudason, MV; Jeyamani, R; Kurian, G; Mukhopadhya, A, 2007) |
"The treatment of melioidosis currently involves the use of antimicrobials such as ceftazidime, trimethoprim-sulfamethoxazole, amoxicillin-clavulanate and doxycycline." | ( Karunakaran, R; Puthucheary, SD, 2007) |
"For eradication therapy for melioidosis, we recommend 20/5 mg/kg orally, three times daily." | ( Chaowagul, W; Cheng, AC; Chetchotisakd, P; Chierakul, W; Currie, BJ; Dance, DA; Limmathurotsakul, D; Peacock, SJ, 2008) |
"Twenty-two patients with culture-proven melioidosis, who were initially given empirical anti-tuberculosis treatment, were retrospectively analysed regarding clinical presentation, laboratory findings and epidemiological features, with a view to determining any significant discriminatory parameter/s that would help distinguish the two diseases." | ( Chakrapani, M; Damodar, S; Lipika, S; Shrikala, B; Vidyalakshmi, K; Vishal, S, 2008) |
"Human melioidosis caused by Burkholderia pseudomallei is a severe septic disease that is associated with high mortality, even under appropriate antibiotic treatment." | ( Chetchotisakd, P; Pannengpetch, P; Panomket, P; Sermswan, RW; Wongratanacheewin, S, 2009) |
"This is a report on localized melioidosis in children, regarding clinical presentation, treatment and the long-term outcomes." | ( Chotechuangnirun, N; Kosalaraksa, P; Lumbiganon, P; Teeratakulpisarn, J, 2011) |
"Successful treatment of melioidosis is difficult due to intrinsic resistance of Bps to various antibacterial agents." | ( Chumjan, W; Hajjar, E; Mahendran, KR; Schulte, A; Suginta, W; Weingart, H; Winterhalter, M, 2011) |
"Burkholderia pseudomallei infection (melioidosis) is an important cause of community-acquired Gram-negative sepsis in Northeast Thailand, where it is associated with a ~40% mortality rate despite antimicrobial chemotherapy." | ( Bast, A; Breitbach, K; de Jong, HK; Hoogendijk, AJ; Kager, LM; Koh, GC; Krause, K; Peacock, SJ; Steinmetz, I; van der Poll, T; Weehuizen, TA; Wiersinga, WJ, 2013) |
"Treatment for melioidosis is unaffordable for many in endemic areas of the developing world, but the relative costs have reduced over the past decade." | ( Dance, D, 2014) |
"We present 11 cases of melioidosis, ranging from localized to disseminated, treated successfully, barring one death." | ( Bhat, V; Eshwara, VK; Kini, P; Mukhopadhyay, C, 2015) |
"We report a case of systemic melioidosis in a 58-year-old diabetic, occupationally-unexposed male patient, who presented with chronic fever, sepsis, pneumonia, pleural effusion and subcutaneous abscess, was undiagnosed for long, misidentified as Pseudomonas aeruginosa infection elsewhere, but was saved due to correct identification of the etiologic agent and timely institution of appropriate therapy at our institute." | ( Mishra, B; Mohanty, S; Mohapatra, PR; Panigrahi, MK; Pradhan, G, 2016) |
"Patients with lung or skin melioidosis require careful treatment follow-up to minimize the chance for secondary osteoarticular infection." | ( Abumarzouq, M; Harun, A; Wan Ismail, WF; Yusof, MI; Zueter, AM, 2017) |
"Delays in diagnosis and in melioidosis-appropriate antibiotic treatment were observed in nearly 90% of children." | ( Bantin, R; Chien, SL; Chieng, CH; Chua, WY; Currie, BJ; Goh, C; Hashim, J; Hii, KC; Machunter, B; Mayo, M; Mijen, A; Mohan, A; Ngian, HU; Ooi, MH; Podin, Y; Rigas, V; Tai, N; Tan, LS; Wong, D; Wong, JS; Wong, SC, 2017) |
"Diagnosis of melioidosis was made by presence high titre of antibodies to melioidin antigen, and rapid response to appropriate treatment." | ( Herath, HMM; Liyanage, TMU; Weerasinghe, NP, 2018) |
"There is no vaccine for melioidosis, and effective eradication is reliant on biphasic and prolonged antibiotic administration." | ( Baird, RW; Currie, BJ; Mayo, M; Pitman, MC; Price, EP; Robson, JM; Sarovich, DS; Viberg, LT; Webb, JR, 2018) |
"After a diagnosis of plague, melioidosis or glanders during an outbreak or after an exposure event, the timely distribution of appropriate antibiotics for treatment or post-exposure prophylaxis of affected populations could reduce mortality rates." | ( McLaughlin, HP; Sue, D, 2018) |
"In patients treated for melioidosis in northern Australia there are high rates of adverse effects from oral trimethoprim-sulfamethoxazole, frequently necessitating a change in therapy or a reduction in dose." | ( Currie, BJ; Sullivan, RP; Ward, L, 2019) |
"In an inhalational model of murine melioidosis, both ΔBPSS0395 and ΔBPSS1584 strains were attenuated, and treatment with levofloxacin led to significant reduction in lung colonisation and reduced splenic colonisation by ΔBPSS0395." | ( Hong-Geller, E; Micheva-Viteva, S; Ross, BN; Torres, AG, 2019) |
"Myositis in melioidosis is uncommon, and careful evaluation is mandatory to avoid misdiagnosis of this treatable but fatal disease." | ( Abeygunawardana, SP; Dalugama, C; Dissanayake, N; Dissanayake, P; Jayalath, T; Jayawardena, N; Kumarihamy, P; Ralapanawa, U; Ratnatunga, N; Udupihille, J, 2019) |
"Treating melioidosis has been a challenge in district hospitals due to high usage of broad spectrum antibiotics and prolonged hospitalisation." | ( Chan, YW; Eileen, T; Lam, JE; Lim, SH; Nurasykin, S; Tang, RY, 2019) |
"Treatment of melioidosis comprises intravenous drugs for at least 10 days, followed by oral trimethoprim-sulfamethoxazole (TMP-SMX) for 12 to 20 weeks." | ( Anunnatsiri, S; Chaisuksant, S; Chaowagul, W; Chetchotisakd, P; Chierakul, W; Day, NPJ; Khemla, S; Kongsawasd, W; Limmathurotsakul, D; Mootsikapun, P; Narenpitak, S; Pattarapongsin, M; Pisuttimarn, P; Tanwisaid, K; Teparrukkul, P; Thipmontree, W, 2021) |
"This report highlights a potential anti-melioidosis treatment failure due to the emergence of resistance while on carbapenem monotherapy." | ( Deris, ZZ; Harun, A; Hasan, H; Muhd Besari, A; Zamani, A; Zueter, AR, 2020) |
"Treatment options are limited for melioidosis patients who develop nosocomial infections due to extensively drug-resistant (XDR) Gram-negative bacilli." | ( Meesing, A; Sribenjalux, W; Wonglakorn, L, 2022) |
"The efficacy of co-trimoxazole against melioidosis acquired by different routes of exposure was assessed in postexposure prophylaxis (PEP) and treatment studies in marmoset models of melioidosis." | ( Atkins, TP; Burton, N; Butcher, W; Nelson, M; Ngugi, S; Nunez, A, 2022) |
"The two stages of melioidosis treatment are the intense intravenous phase and the oral eradication phase." | ( Gunathilaka, MGRSS; Jayaweera, JAAS; Keragala, KARK; Senevirathna, RMISK, 2023) |